Full Text View
Tabular View
No Study Results Posted
Related Studies
EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma (CARCD30)
This study is currently recruiting participants.
Verified February 2013 by Baylor College of Medicine
Study NCT01192464   Information provided by Baylor College of Medicine

First Received on August 16, 2010.   Last Updated on February 12, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Additional conditions recognized in this trial
Hodgkin Disease
Lymphoma
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Sponsors listed in this trial
Baylor College of Medicine
Center for Cell and Gene Therapy, Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services